Identification of ATM Mutations in Multiple Myeloma Tumours.

Belinda Austen , Maria Podinovskaia , Jane Starcynski , Giancarlo Barone
Blood 106 ( 11) 1562 -1562

2005
Bortezomib, Melphalan, Dexamethasone: A New Standard of Care for AL Amyloidosis?

Guy Pratt
Journal of Clinical Oncology 38 ( 28) 3243 -3244

2020
Biclonal Multiple Myeloma with Monoclonal Free IgG3 Heavy Chain and kappa Free Light Chains.

Alex G. Richter , Stephen Harding , Steve Rimmer , Guy Pratt
Blood 110 ( 11) 4768 -4768

2007
A Common Genetic Variant in the 3′UTR of IRF4/MUM1 Associates with Risk of Disease and Poor Prognosis in Chronic Lymphocytic Leukaemia.

James M Allan , Nicola Sunter , Andrew Hall , Tryfonia Mainou-Fowler
Blood 112 ( 11) 1060 -1060

2008
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells.

Karl R. N. Baumforth , Joanne R. Flavell , Gary M. Reynolds , Gillian Davies
Blood 106 ( 6) 2138 -2146

107
2005
The intranet age: Decreasing delays to diagnosis of lymphoma

Iain Parsons , Guy Pratt , Ijaz Ahmad , Richard Steyn
British Journal of Healthcare Management 21 ( 4) 189 -194

2015
Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL

Marwan Kwok , Ceri Oldreive , Andy C. Rawstron , Anshita Goel
Blood 135 ( 6) 411 -428

4
2020
Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia

Helen Marie Parry , Sarah Damery , Christopher Hudson , Matthew J. Maurer
American Journal of Hematology 91 ( 8) 776 -781

10
2016
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.

Angelo Agathanggelou , Edward Smith , Nicholas J. Davies , Marwan Kwok
Blood 130 ( 2) 156 -166

36
2017
RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

Michael A. Chapman , Jonathan Sive , John Ambrose , Claire Roddie
Blood 132 ( 20) 2154 -2165

16
2018
4.1 Elevated Serum Free Light Chains Independently Identify a Poor Risk Group of Stage A CLL Patients

Guy Pratt , Philip J. Young , Chris Pepper , Chris Fegan
Clinical Lymphoma Myeloma and Leukemia 11 S218

1
2011
4.24 Telomere Dysfunction is the Critical Determinant of Clinical Outcome in CLL

Thet Thet Lin , Guy Pratt , Robert Hills , Bethan Britt-Compton
Clinical Lymphoma Myeloma and Leukemia 11 S234 -S235

2011